Showing results (1-10 of 18) with videos related to
Sort By:
Pageof 2
Current Opinion in Oncology|May 1, 1997
Advances and controversies in the management of childhood brain tumorsJ F KutteschCancer Chemotherapy and Pharmacology|January 1, 1982
Renal handling of 2'-deoxyadenosine and adenosine in humans and miceJ F Kuttesch, J A NelsonBiochemical Pharmacology|November 1, 1982
Renal transport of 2'-deoxytubercidin in miceJ F Kuttesch, M J Robins, J A NelsonMolecular Pharmacology|September 1, 1993
Pharmacological characterization of N-substituted phenoxazines directed toward reversing Vinca alkaloid resistance in multidrug-resistant cancer cellsJ K Horton, K N Thimmaiah, F C Harwood, et al.Cancer Chemotherapy and Pharmacology|January 1, 1996
Cerebrospinal fluid pharmacokinetics and penetration of continuous infusion topotecan in children with central nervous system tumorsS D Baker, R L Heideman, W R Crom, et al.Molecular Pharmacology|May 1, 1994
Cross-resistance to antitumor diarylsulfonylureas and collateral sensitivity to mitochondrial toxins in a human cell line selected for resistance to the antitumor agent N-(5-indanylsulfonyl)-N'-(4-chlorophenyl)ureaJ Sosinski, J H Thakar, G S Germain, et al.Cancer|January 1, 1995
Embryonal malignancies of unknown primary origin in childrenJ F Kuttesch, D M Parham, S C Kaste, et al.Medical and Pediatric Oncology|May 1, 1995
Malignant melanocytic lesions of unknown primary site in children and adolescentsA S Pappo, J F Kuttesch, S C Kaste, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1994
Phase I study of topotecan for pediatric patients with malignant solid tumorsC B Pratt, C Stewart, V M Santana, et al.Pageof 2